Form 4 Filing for AtriCure, Inc. - Insider Transaction

This filing details a transaction by Vinayak Doraiswamy, Chief Scientific Officer of AtriCure, Inc. On June 30, 2026, Doraiswamy acquired 636 shares of the company's Common Stock through the AtriCure, Inc. 2018 Employee Stock Purchase Plan. The acquisition price was $23.78 per share, which represents 85% of the closing stock price on the transaction date. Following this transaction, Doraiswamy directly owns 92,511 shares of AtriCure, Inc. Common Stock. The transaction was reported on Form 4 and signed on July 2, 2026.